David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), sold 55 shares at $2.42 ($133) on 2024-09-13, disclosed to the SEC on 2024-09-17.
Open-market sale of $133 TTOO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTOO | BUY | 2018-06-05 | $32K | — | Filing → |
| TTOO | BUY | 2017-11-17 | $6K | — | Filing → |
| TTOO | BUY | 2017-06-08 | $35K | — | Filing → |